34 reports

  • Liver Cancer Overview
  • III. LIVER CANCER TREATMENT DRUGS

The liver cancer treatment drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Liver Cancer
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Liver Cancer Treatment Drugs Companies in China
  • Liver Cancer Treatment Drugs Industry Structure

The liver cancer treatment drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Liver Cancer
  • China
  • Biostar Pharmaceuticals, Inc.
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Liver Cancer Overview
  • IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for liver cancer treatment drugs in China is growing rapidly.

  • Liver Cancer
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited

Liver Cancer Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Liver Cancer
  • APAC
  • World
  • Market Size

Liver Cancer Diagnostic Market Size, Share & Trends Analysis Report By Screening Type, By Region And Segment Forecasts, 2019 - 2025 Chapter ## Methodology and Scope ##. ## Research Methodology ##. ##. ## Information Procurement ##. ## Information or Data Analysis ##. ## Research Scope and Ass

  • Cancer
  • Liver Cancer
  • North America
  • United States
  • Market Size

Liver Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Cancer
  • Liver Cancer
  • United Kingdom
  • United States
  • Forecast
  • FEATURES OF LIVER CANCER PATIENTS
  • Incidence of Liver Cancer, females (000s)

HPB. 2005; ##(##):##-##. ##.

  • Cancer
  • Hepatitis
  • Liver Cancer
  • Pathology

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Liver Cancer
  • France
  • United States
  • Market Shares
  • Market Size

Liver Cancer Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials in Asia-Pacific Top F

  • Clinical Trial
  • Liver Cancer
  • Pharmaceutical
  • Therapy
  • World
  • Liver Cancer Diagnostic Tests Companies and Product
  • Liver Cancer Diagnostic Tests - Pipeline Products under Development by

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 H e a l t h c a r e H e a l t h c a r e Report Code: Published: GDME##EPD November 2019 ## ## ## ## ## ## ## ## Ymir Genomics LLC.

  • Cancer
  • Clinical Trial
  • Hepatitis
  • Liver Cancer
  • Pfizer Inc.

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Liver Cancer
  • France
  • Germany
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Japan
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • United States
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Germany
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Italy
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • France
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • United Kingdom
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Spain
  • Market Shares
  • Market Size

The report focuses on drugs and therapies being evaluated for Metastatic Liver Cancer treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Cancer
  • Clinical Trial
  • Drug Development
  • Liver Cancer
  • Pathology
  • 7.5 United States - Liquid Biopsy Liver Cancer Treatment Monitoring
  • 6.5 United States - Liquid Biopsy Liver Cancer Screening Potential

Liver Cancer The Top ## Cancer Segments covered are: ##.

  • Liver Cancer
  • North America
  • United States
  • Forecast
  • Biocept, Inc.
  • 4.4.1 United States - Liver Cancer Biopsy Test Market & Forecast
  • 4.4 United States - Liver Cancer Biopsy Test Market & Volume

Surgical Biopsy ##.

  • Biopsy
  • Liver Cancer
  • Prostate Cancer
  • United States
  • Forecast
  • JUN 19, 2018: CAN-FITE UPDATES ON STATUS OF PHASE II ADVANCED LIVER CANCER TRIAL
  • NOV 04, 2019: CAN-FITE INITIATES COMPASSIONATE USE PROGRAM FOR NAMODENOSON IN THE TREATMENT OF LIVER CANCER, ENROLLS AND TREATS PATIENTS

Fishman is scheduled to conduct one-on-one meetings with potential commercialization and out-licensing partners.

  • Autoimmune Disease
  • Liver Cancer
  • United States
  • Product Initiative
  • Can-Fite BioPharma Ltd.
  • Symptoms of Liver Cancer
  • Liver Cancer, Molecular Target Category

A poor quality diet, particularly one characterized by high alcohol consumption, is another significant risk factor in liver cancer.

  • Cancer
  • Hepatitis
  • Liver Cancer
  • Pathology
  • Therapy

Liver cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Liver Cancer
  • United States
  • Product Initiative
  • SMALL MOLECULES FOR AUTOIMMUNE DISORDERS, INFLAMMATION, LIVER CANCER AND METABOLIC DISORDERS - DRUG PROFILE
  • AUG 09, 2017: CAN-FITE COMPLETES PATIENT ENROLMENT FOR ITS PHASE II STUDY OF NAMODENOSON IN THE TREATMENT OF LIVER CANCER

Titled " Programmed Death ##/ Programmed Death Ligand ## (PD-##/ PD-L##) Axis Inhibitor For Use In Combination With An A## Adenosine Receptor (A##AR) Ligands", the patent application addresses various oncology indications including advanced hepatocellular carcin

  • Liver Cancer
  • Therapy
  • World
  • Product Initiative
  • Can-Fite BioPharma Ltd.

Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase ##, Preclinical and Discovery stages comprises ##, ##, ##, ##, ## and ## molecules, respectively.

  • Cancer
  • Liver Cancer
  • Pathology
  • Pharmaceutical
  • Therapy

Liver Cancer - Pipeline Review, H## 2016 Table of Contents Table of Contents ## Introduction ## Liver Cancer Overview ## Therapeutics Development ## Liver Cancer - Therapeutics under Development by Companies ## Liver Cancer - Therapeutics under Investigation by Unive

  • Cancer
  • Liver Cancer
  • Pathology
  • Pharmaceutical
  • Therapy
  • NBTXR3 - LIVER CANCER
  • NBTXR3 - LIVER CANCER PRODUCT OVERVIEW

## Liver Cancer ## Lung Cancer ## Pancreatic Cancer ## Prostate Cancer ## Rectal Diseases ## Soft Tissue Cancer ## Nanobiotix SA Ongoing Clinical Trials by Trial Status Ongoing, Recruiting ## Planned ## Ongoing, not Recruiting

  • Liver Cancer
  • Neck Cancer
  • United States
  • Product Initiative
  • Nanobiotix
  • Clinical Trial profile. 65 Trial Title
  • Clinical Trial profile. 78 Trial Title

Bonafede / PosterDate/ Time (EDT): Oct. ##, 2017, ##:## - ##:## p. m. Location/ Session: Clinical Liver Cancer, Hall D About OpdivoOpdivo is a programmed death-## (PD-##) immune checkpoint inhibitor that is designed to uniquely harness the body' s own immune sy

  • Hepatitis
  • Hospital
  • Liver Cancer
  • World
  • Product Initiative
  • SURVIVIN-IGM KIT - LIVER CANCER
  • COMPLEXIMA HCC BIOCHIP - LIVER CANCER

Liver Cancer ## Breast Cancer ## Colorectal Cancer ## Esophageal Cancer ## Cervical Cancer ## Lung Cancer ## Non-Alcoholic Steato-Hepatitis (NASH) ## Prostate Cancer ## Scleroderma ## Indication No of Products XEPTAGEN SPA - PIPELINE ANALYSIS OVE

  • Bioinformatics
  • Cancer
  • In Vitro Diagnostics
  • Liver Cancer